5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 0.66▲ | 0.66▲ | 0.66▲ | 0.68▼ | 0.75▼ |
MA10 | 0.66▲ | 0.66▲ | 0.66▲ | 0.70▼ | 0.68▼ |
MA20 | 0.66▲ | 0.66▲ | 0.67▼ | 0.76▼ | 0.58▲ |
MA50 | 0.66▲ | 0.68▼ | 0.68▼ | 0.66▲ | 1.30▼ |
MA100 | 0.67▼ | 0.69▼ | 0.74▼ | 0.58▲ | 2.44▼ |
MA200 | 0.67▼ | 0.76▼ | 0.72▼ | 1.15▼ | 5.05▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.001▲ | 0.001▲ | 0.001▲ | -0.021▼ | 0.089▲ |
RSI | 57.195▲ | 50.275▲ | 47.693▼ | 44.678▼ | 43.521▼ |
STOCH | 87.298▲ | 35.141 | 34.954 | 15.510▼ | 65.343 |
WILL %R | -14.179▲ | -41.108 | -67.472 | -89.638▼ | -47.644 |
CCI | 169.289▲ | 65.223 | -12.922 | -77.285 | 42.541 |
Friday, August 08, 2025 05:10 AM
Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
08/08/25 | 0.67 | 0.6832 | 0.6484 | 0.6689 | 1,253,923 |
07/08/25 | 0.68 | 0.7098 | 0.6459 | 0.6632 | 1,935,554 |
06/08/25 | 0.6954 | 0.715 | 0.6705 | 0.6746 | 865,528 |
05/08/25 | 0.70 | 0.716 | 0.685 | 0.6954 | 1,109,867 |
04/08/25 | 0.67 | 0.6933 | 0.6423 | 0.6933 | 1,561,949 |
01/08/25 | 0.69 | 0.69 | 0.6441 | 0.6706 | 1,589,449 |
31/07/25 | 0.72 | 0.74 | 0.6614 | 0.676 | 2,205,945 |
30/07/25 | 0.715 | 0.799 | 0.6935 | 0.7343 | 3,060,911 |
29/07/25 | 0.7868 | 0.79 | 0.69 | 0.7042 | 2,767,137 |
28/07/25 | 0.83 | 0.8332 | 0.76 | 0.7799 | 2,577,687 |
|
|
||||
|
|
||||
|
|